TY - JOUR
T1 - Time-Driven Activity-Based Costing Analysis of Telemedicine Services in Radiation Oncology
AU - Parikh, Neil R.
AU - Chang, Eric M.
AU - Kishan, Amar U.
AU - Kaprealian, Tania B.
AU - Steinberg, Michael L.
AU - Raldow, Ann C.
N1 - Funding Information:
Disclosures: A.U.K. reports honoraria and consulting fees from Varian, honoraria from ViewRay, serving on the Janssen advisory board, and consulting fees from Intelligent Automation Inc. M.L.S. reports honoraria from ViewRay and consulting fees from Vision RT. A.C.R. reports consulting fees from Intelligent Automation Inc, honoraria from Varian Medical System Inc, consulting fees/honoraria/in-kind donations from Clarity PSO/RO-ILS RO-HAC, honoraria from California Technology Assessment Forum, consulting fees and honoraria from Rectal Cancer Panel Member, grants from ViewRay Inc, and serving on the NCCN EHR Advisory Group.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Purpose: Health systems have increased telemedicine use during the SARS-CoV-2 outbreak to limit in-person contact. We used time-driven activity-based costing to evaluate the change in resource use associated with transitioning to telemedicine in a radiation oncology department. Methods and Materials: Using a patient undergoing 28-fraction treatment as an example, process maps for traditional in-person and telemedicine-based workflows consisting of discrete steps were created. Physicians/physicists/dosimetrists and nurses were assumed to work remotely 3 days and 1 day per week, respectively. Mapping was informed by interviews and surveys of personnel, with cost estimates obtained from the department's financial officer. Results: Transitioning to telemedicine reduced provider costs by $586 compared with traditional workflow: $47 at consultation, $280 during treatment planning, $237 during on-treatment visits, and $22 during the follow-up visit. Overall, cost savings were $347 for space/equipment and $239 for personnel. From an employee perspective, the total amount saved each year by not commuting was $36,718 for physicians (7243 minutes), $19,380 for physicists (7243 minutes), $17,286 for dosimetrists (7210 minutes), and $5599 for nurses (2249 minutes). Patients saved $170 per treatment course. Conclusions: A modified workflow incorporating telemedicine visits and work-from-home capability conferred savings to a department as well as significant time and costs to health care workers and patients alike.
AB - Purpose: Health systems have increased telemedicine use during the SARS-CoV-2 outbreak to limit in-person contact. We used time-driven activity-based costing to evaluate the change in resource use associated with transitioning to telemedicine in a radiation oncology department. Methods and Materials: Using a patient undergoing 28-fraction treatment as an example, process maps for traditional in-person and telemedicine-based workflows consisting of discrete steps were created. Physicians/physicists/dosimetrists and nurses were assumed to work remotely 3 days and 1 day per week, respectively. Mapping was informed by interviews and surveys of personnel, with cost estimates obtained from the department's financial officer. Results: Transitioning to telemedicine reduced provider costs by $586 compared with traditional workflow: $47 at consultation, $280 during treatment planning, $237 during on-treatment visits, and $22 during the follow-up visit. Overall, cost savings were $347 for space/equipment and $239 for personnel. From an employee perspective, the total amount saved each year by not commuting was $36,718 for physicians (7243 minutes), $19,380 for physicists (7243 minutes), $17,286 for dosimetrists (7210 minutes), and $5599 for nurses (2249 minutes). Patients saved $170 per treatment course. Conclusions: A modified workflow incorporating telemedicine visits and work-from-home capability conferred savings to a department as well as significant time and costs to health care workers and patients alike.
UR - http://www.scopus.com/inward/record.url?scp=85090008102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090008102&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2020.06.053
DO - 10.1016/j.ijrobp.2020.06.053
M3 - Editorial
C2 - 32890526
AN - SCOPUS:85090008102
SN - 0360-3016
VL - 108
SP - 430
EP - 434
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 2
ER -